{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:44:37Z","timestamp":1789789477036,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.ijtb.2024.05.013","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:35:57Z","timestamp":1717202157000},"page":"S91-S96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S1","title":["Isoniazid monoresistant tuberculosis treatment outcomes in Puducherry, South India - A mixed methods study"],"prefix":"10.1016","volume":"71","author":[{"given":"Arifunhera","family":"J","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1790-6103","authenticated-orcid":false,"given":"Mirunalini","family":"R","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palanivel","family":"Chinnakali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2024.05.013_bib1","series-title":"Definitions and Reporting Framework for Tuberculosis \u2013 2013 Revision: Updated December 2014 and January 2020","year":"2013"},{"key":"10.1016\/j.ijtb.2024.05.013_bib2","series-title":"Global Tuberculosis Report 2020 [Internet]","year":"2020"},{"key":"10.1016\/j.ijtb.2024.05.013_bib3","series-title":"Guidelines for Programmatic Management of Drug-Resistant Tuberculosis in India","year":"2021"},{"key":"10.1016\/j.ijtb.2024.05.013_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(16)30407-8","article-title":"Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis","volume":"17","author":"Gegia","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijtb.2024.05.013_bib5","series-title":"WHO Treatment Guidelines for Isoniazid-Resistant Tuberculosis: Supplement to the WHO Treatment Guidelines for Drug-Resistant Tuberculosis","year":"2018"},{"key":"10.1016\/j.ijtb.2024.05.013_bib6","series-title":"Guidelines for Programmatic Management of Drug Resistant Tuberculosis in India","year":"2017"},{"key":"10.1016\/j.ijtb.2024.05.013_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076189","article-title":"The impact of isoniazid resistance on the treatment outcomes of smear positive Re-treatment tuberculosis patients in the state of Andhra Pradesh, India","volume":"8","author":"Deepa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijtb.2024.05.013_bib8","series-title":"National Tuberculosis Elimination Programme. Annual Report","year":"2020"},{"key":"10.1016\/j.ijtb.2024.05.013_bib9","series-title":"National Tuberculosis Elimination Programme. Annual Report","year":"2021"},{"key":"10.1016\/j.ijtb.2024.05.013_bib10","series-title":"National Tuberculosis Elimination Programme. Annual Report","year":"2022"},{"key":"10.1016\/j.ijtb.2024.05.013_bib11","series-title":"Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care [Internet]. 2017 Update","first-page":"80","year":"2017"},{"key":"10.1016\/j.ijtb.2024.05.013_bib12","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3390\/ijerph18062965","article-title":"Treatment outcomes of isoniazid-resistant (rifampicin susceptible) tuberculosis patients in Uzbekistan, 2017-2018","volume":"18","author":"Sayfutdinov","year":"2021","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.ijtb.2024.05.013_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijid.2021.03.093","article-title":"Isoniazid-monoresistant tuberculosis in France: risk factors, treatment outcomes and adverse events","volume":"107","author":"Bachir","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijtb.2024.05.013_bib14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.15537\/smj.2021.42.6.20200832","article-title":"Prevalence and outcome of isoniazid-monoresistant tuberculosis at a university hospital in Saudi Arabia","volume":"42","author":"Binkhamis","year":"2021","journal-title":"SMJ"},{"key":"10.1016\/j.ijtb.2024.05.013_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106163","article-title":"Management of isoniazid-monoresistant tuberculosis (Hr-TB) in Queensland, Australia: a retrospective case series","volume":"173","author":"Wilson","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.ijtb.2024.05.013_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/lungindia.lungindia_204_19","article-title":"Pattern of InhA and KatG mutations in isoniazid monoresistant Mycobacterium tuberculosis isolates","volume":"37","author":"Charan","year":"2020","journal-title":"Lung India"},{"key":"10.1016\/j.ijtb.2024.05.013_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jgar.2018.02.009","article-title":"Prevalence of mutations in genes associated with isoniazid resistance in Mycobacterium tuberculosis isolates from re-treated smear-positive pulmonary tuberculosis patients: a meta-analysis","volume":"14","author":"Alagappan","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijtb.2024.05.013_bib18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.5588\/ijtld.15.0864","article-title":"Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis","volume":"20","author":"Bollela","year":"2016","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis."},{"key":"10.1016\/j.ijtb.2024.05.013_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac516","article-title":"Agreement between measures of adherence to isoniazid preventive therapy among people with HIV in Uganda","volume":"9","author":"Forman","year":"2022","journal-title":"Open Forum Infect Dis"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001957072400088X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001957072400088X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T08:04:48Z","timestamp":1747123488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001957072400088X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":19,"alternative-id":["S001957072400088X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2024.05.013","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoniazid monoresistant tuberculosis treatment outcomes in Puducherry, South India - A mixed methods study","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2024.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of Tuberculosis Association of India.","name":"copyright","label":"Copyright"}]}}